<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="interaction" /><meta name="keywords" content="" /><title>Phenobarbital: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../383/theme.css" /><link type="text/css" rel="stylesheet" href="204/style.css" /><link type="image/x-icon" rel="shortcut icon" href="../../favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="PHP0-publication-information.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="bnf_int437-phenobarbital.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.8/jquery.min.js"></script><script type="text/javascript" src="../../383/scripts.js"></script><style type="text/css">
          .contentsbox { position: fixed; z-index:1001; }
          .contentsbox_wrap { overflow: hidden; width: 20px; height: 130px; position: absolute; left: 0; top: 0; }
        </style><!--[if IE 8]>
          <style type="text/css">
          #p1 {
          float: left;
          padding-bottom: 15em;
          }
          </style>
          <![endif]--><!--[if lte IE 8]>
          <style type="text/css">
          #start-search input {
          height: 28px;
          padding-top: 8px;
          }
          @media screen {
          #pV {
          display: block !important;
          }
          }
          </style>
          <![endif]--><!--[if IE 7]>
          <style type="text/css">
          #start-search input {
          position: absolute !important;
          left: 0;
          top: 0;
          }
          .as-shadow {
          margin-left: -4px !important;
          color: silver;
          }
          </style>
          <![endif]--><!--[if lte IE 7]>
          <style type="text/css">
          .menu {
          height: 1%;
          }
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }

          #account-info ul li a {
          width: 12em;
          }
          #opts ul li span {
          width: 12em;
          }
          div.as-select ul li ul li span {
          width: 40em;
          }
          div.menu ul li ul li {
          float: left !important;
          }
          #pQ fieldset, #qd, #input-box, #pub-list, #start-search, #end-search {
          display: inline;
          float: left;
          height: 100%;
          padding: 0;
          margin: 0;
          position: relative;
          }
          #hM a, #hM a img {
          border: none;
          display: inline-block;
          float: left;
          }
          #qd input {
          float: left;
          display: inline-block !important;
          }
          #start-search input {
          height: 28px;
          padding-top: 8px !important;
          }
          #end-search, #end-search input {
          height: 36px !important;
          }
          #hM, #content, #searchForm, #purple-menu {
          width: expression(document.body.clientWidth > 63 * parseInt(document.body.currentStyle.fontSize) ? '63em': 'auto');
          margin: 0 auto;
          }
          #pQ {
          z-index: 1;
          }
          </style>
          <![endif]--><!--[if lte IE 6]>
          <style type="text/css">
          body {
          height: 100%;
          }
          div.menu ul li a, div.menu ul li span {
          display: inline-block;
          }
          div.menu ul li ul li {
          clear: both;
          }
          div.as-select ul li span {
          height: 20px;
          padding-top: 16px;
          padding-left: 1em;
          padding-bottom: 0;
          padding-left: 1em;
          margin: 4px 0;
          border-right: 1px solid #888;
          background-image: url("images/dropdown_img.png");
          background-repeat: repeat-x;
          overflow-x: hidden;
          }
          div.as-select ul li ul li span {
          font: bold 10px Verdana !important;
          padding: 4px 1em !important;
          color: #2D2D2D;
          background: white;
          text-decoration: none !important;
          white-space: nowrap;
          border: none !important;
          float: left;
          }
          div.menu span.hover {
          background: #8F1F8D;
          color: white;
          }
          </style>
          <![endif]--></head><body><!--[if lte IE 6]>
          <script type="text/javascript">
          jQuery(document).ready(function($) {
          $('a.mclogo').html('<img src="images/mc_logo.gif" class="logo" />');
          });
          </script>
          <![endif]--><?highlighter off?><div id="hC"><div id="vH"><div id="pU"><a class="mclogo" href="http://www.medicinescomplete.com/about/"><img class="logo" src="../../images/mc_logo.png" alt="MedicinesComplete" /></a><div id="hM"><div id="vM" class="menu"><ul><li><a href="http://www.medicinescomplete.com/mc/index.htm">Home</a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm">Help</a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=bnf_int437-phenobarbital.htm">Feedback</a></li><li id="account-info"><a href="http://www.medicinescomplete.com/mc/account.htm">BNF.org Free Access</a><ul><li><a href="http://www.medicinescomplete.com/mc/account.htm">My Account</a></li><li><a href="http://www.medicinescomplete.com/mc/subscribe.htm">Subscribe</a></li><li><a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li><a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul></li></ul></div><a id="pD" accesskey="s" rel="bookmark" href="bnf_int437-phenobarbital.htm#pB" title="Skip Navigation">Skip Navigation</a></div></div><div id="pA"><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 13 Mar 2013 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="search-in">Publication</label><label for="q">Search for</label><div id="qd"><div id="start-search"><div class="as-select menu" id="pub-list"><ul><li><span>British National Formulary</span><ul></ul></li></ul></div><div id="input-box"><input type="text" id="q" name="q" accesskey="4" /></div></div><div id="end-search"><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div></div></div><div id="pH"><div id="pN"><div id="pT"><!--[if lte IE 7]>
             
            <![endif]--><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF March 2013</a> &gt; <a href="PHP8848-interactions.htm">Appendix 1 Interactions</a> &gt; <a href="PHP8852-list-of-drug-interactions.htm">List of drug interactions</a> &gt; <a href="bnf_int276-antiepileptics.htm">Antiepileptics</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="bnf_int1195-retigabine.htm" title="Previous: Retigabine">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="bnf_int1003-primidone.htm" title="Next: Primidone">Next page</a> ►</div></div></div></div><div id="content"><div id="p1"><div id="pB"><?highlighter on?><h1>Phenobarbital</h1><?highlighter off?><?highlighter on?><div id="pC" class="jN"><p><strong>Phenobarbital</strong> has the following interaction information:</p><table summary="Drug interactions" width="100%" border="0" cellspacing="2"><colgroup><col width="30%" class="cAG" /><col width="40%" class="cAF" /><col width="30%" class="cAH" /></colgroup><tbody><tr><td><a href="bnf_int907-abacavir.htm">Abacavir</a></td><td><p><span></span> <span>phenobarbital</span> <span>possibly reduces plasma concentration of</span> <span>abacavir</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int20-alcohol.htm">Alcohol</a></td><td><p><span>increased sedative effect when </span><span>phenobarbital</span> <span>given with</span> <span>alcohol</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int241-antidepressants-tricyclic.htm">Antidepressants, Tricyclic</a></td><td class="cAI"><p><span></span> <span>phenobarbital</span> <span>possibly accelerates metabolism of</span> <span>tricyclics</span> <span>(reduced plasma concentration)</span></p></td><td></td></tr><tr><td><a href="bnf_int1010-aprepitant.htm">Aprepitant</a></td><td><p><span></span> <span>phenobarbital</span> <span>possibly reduces plasma concentration of</span> <span>aprepitant</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int1011-aripiprazole.htm">Aripiprazole</a></td><td class="cAI"><p><span></span> <span>phenobarbital</span> <span>possibly reduces plasma concentration of</span> <span>aripiprazole</span><span>—increase dose of <span>aripiprazole</span></span></p></td><td></td></tr><tr><td><a href="bnf_int1235-axitinib.htm">Axitinib</a></td><td><p><span></span> <span>phenobarbital</span> <span>possibly decreases plasma concentration of</span> <span>axitinib</span> <span>(increase dose of <span>axitinib</span>—consult <span>axitinib</span> product literature)</span></p></td><td></td></tr><tr><td><a href="bnf_int1214-boceprevir.htm">Boceprevir</a></td><td class="cAI"><p><span>avoidance of </span><span>phenobarbital</span> <span>advised by manufacturer of</span> <span>boceprevir</span> <span>(plasma concentration of <span>boceprevir</span> possibly reduced)</span></p></td><td></td></tr><tr><td><a href="bnf_int1204-cabazitaxel.htm">Cabazitaxel</a></td><td class="cAI"><p><span>avoidance of </span><span>phenobarbital</span> <span>advised by manufacturer of</span> <span>cabazitaxel</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int466-calcium-channel-blockers.htm">Calcium-channel Blockers</a></td><td class="cAI"><p><span></span> <span>phenobarbital</span> <span>probably reduces effects of</span> <span>calcium-channel blockers</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int277-carbamazepine.htm">Carbamazepine</a></td><td><p><span>plasma concentration of </span><span>phenobarbital</span> <span>possibly increased by</span> <span>carbamazepine</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int550-carbonic-anhydrase-inhibitors.htm">Carbonic Anhydrase Inhibitors</a></td><td><p><span>increased risk of osteomalacia when </span><span>phenobarbital</span> <span>given with</span> <span>carbonic anhydrase inhibitors</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int158-chloramphenicol.htm">Chloramphenicol</a></td><td class="cAI"><p><span></span> <span>phenobarbital</span> <span>possibly accelerates metabolism of</span> <span>chloramphenicol</span> <span>(reduced plasma concentration)</span></p></td><td></td></tr><tr><td><a href="bnf_int374-chlorpromazine.htm">Chlorpromazine</a></td><td><p><span>plasma concentration of both drugs reduced when </span><span>phenobarbital</span> <span>given with</span> <span>chlorpromazine</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int499-ciclosporin.htm">Ciclosporin</a></td><td class="cAI"><p><span></span> <span>phenobarbital</span> <span>accelerates metabolism of</span> <span>ciclosporin</span> <span>(reduced plasma concentration)</span></p></td><td></td></tr><tr><td><a href="bnf_int408-clonazepam.htm">Clonazepam</a></td><td><p><span></span> <span>phenobarbital</span> <span>often reduces plasma concentration of</span> <span>clonazepam</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int364-clozapine.htm">Clozapine</a></td><td><p><span></span> <span>phenobarbital</span> <span>possibly reduces plasma concentration of</span> <span>clozapine</span> <span></span></p></td><td><div class="cG"><p><strong>Note:</strong> Avoid concomitant use of clozapine with drugs that have a substantial potential for causing agranulocytosis</p></div></td></tr><tr><td><a href="bnf_int484-corticosteroids.htm">Corticosteroids</a></td><td class="cAI"><p><span></span> <span>phenobarbital</span> <span>accelerates metabolism of</span> <span>corticosteroids</span> <span>(reduced effect)</span></p></td><td><div class="cG"><p><strong>Note:</strong> Interactions do not generally apply to corticosteroids used for topical action (including inhalation) unless specified</p></div></td></tr><tr><td><a href="bnf_int220-coumarins.htm">Coumarins</a></td><td class="cAI"><p><span></span> <span>phenobarbital</span> <span>accelerates metabolism of</span> <span>coumarins</span> <span>(reduced anticoagulant effect)</span></p></td><td><div class="cG"><p><strong>Note:</strong> Change in patient's clinical condition, particularly associated with liver disease, intercurrent illness, or drug administration, necessitates more frequent testing. Major changes in diet (especially involving salads and vegetables) and in alcohol consumption may also affect anticoagulant control</p></div></td></tr><tr><td><a href="bnf_int1240-crizotinib.htm">Crizotinib</a></td><td><p><span></span> <span>phenobarbital</span> <span>possibly reduces plasma concentration of</span> <span>crizotinib</span><span>—manufacturer of <span>crizotinib</span> advises avoid concomitant use</span></p></td><td></td></tr><tr><td><a href="bnf_int1091-darunavir.htm">Darunavir</a></td><td><p><span></span> <span>phenobarbital</span> <span>possibly reduces plasma concentration of</span> <span>darunavir</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int119-disopyramide.htm">Disopyramide</a></td><td><p><span></span> <span>phenobarbital</span> <span>accelerates metabolism of</span> <span>disopyramide</span> <span>(reduced plasma concentration)</span></p></td><td></td></tr><tr><td><a href="bnf_int212-doxycycline.htm">Doxycycline</a></td><td><p><span></span> <span>phenobarbital</span> <span>accelerates metabolism of</span> <span>doxycycline</span> <span>(reduced plasma concentration)</span></p></td><td></td></tr><tr><td><a href="bnf_int1176-dronedarone.htm">Dronedarone</a></td><td class="cAI"><p><span></span> <span>phenobarbital</span> <span>possibly reduces plasma concentration of</span> <span>dronedarone</span><span>—avoid concomitant use</span></p></td><td></td></tr><tr><td><a href="bnf_int1025-eplerenone.htm">Eplerenone</a></td><td class="cAI"><p><span></span> <span>phenobarbital</span> <span>reduces plasma concentration of</span> <span>eplerenone</span><span>—avoid concomitant use</span></p></td><td></td></tr><tr><td><a href="bnf_int281-ethosuximide.htm">Ethosuximide</a></td><td><p><span></span> <span>phenobarbital</span> <span>possibly reduces plasma concentration of</span> <span>ethosuximide</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int1031-etoposide.htm">Etoposide</a></td><td><p><span></span> <span>phenobarbital</span> <span>possibly reduces plasma concentration of</span> <span>etoposide</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int1135-etravirine.htm">Etravirine</a></td><td><p><span>avoidance of </span><span>phenobarbital</span> <span>advised by manufacturer of</span> <span>etravirine</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int860-folates.htm">Folates</a></td><td><p><span>plasma concentration of </span><span>phenobarbital</span> <span>possibly reduced by</span> <span>folates</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int1019-fosamprenavir.htm">Fosamprenavir</a></td><td><p><span></span> <span>phenobarbital</span> <span>possibly reduces plasma concentration of</span> <span>fosamprenavir</span> <span></span></p></td><td><div class="cG"><p><strong>Note:</strong> Fosamprenavir is a prodrug of amprenavir</p></div></td></tr><tr><td><a href="bnf_int1170-gefitinib.htm">Gefitinib</a></td><td><p><span>avoidance of </span><span>phenobarbital</span> <span>advised by manufacturer of</span> <span>gefitinib</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int291-griseofulvin.htm">Griseofulvin</a></td><td><p><span></span> <span>phenobarbital</span> <span>reduces absorption of</span> <span>griseofulvin</span> <span>(reduced effect)</span></p></td><td></td></tr><tr><td><a href="bnf_int387-haloperidol.htm">Haloperidol</a></td><td><p><span></span> <span>phenobarbital</span> <span>accelerates metabolism of</span> <span>haloperidol</span> <span>(reduced plasma concentration)</span></p></td><td></td></tr><tr><td><a href="bnf_int398-indinavir.htm">Indinavir</a></td><td class="cAI"><p><span></span> <span>phenobarbital</span> <span>possibly reduces plasma concentration of</span> <span>indinavir</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int1006-irinotecan.htm">Irinotecan</a></td><td><p><span></span> <span>phenobarbital</span> <span>reduces plasma concentration of</span> <span>irinotecan</span> <span>and its active metabolite</span></p></td><td></td></tr><tr><td><a href="bnf_int472-isradipine.htm">Isradipine</a></td><td><p><span>avoidance of </span><span>phenobarbital</span> <span>advised by manufacturer of</span> <span>isradipine</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int302-itraconazole.htm">Itraconazole</a></td><td><p><span></span> <span>phenobarbital</span> <span>possibly reduces plasma concentration of</span> <span>itraconazole</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int283-lamotrigine.htm">Lamotrigine</a></td><td><p><span></span> <span>phenobarbital</span> <span>reduces plasma concentration of</span> <span>lamotrigine</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int922-lopinavir.htm">Lopinavir</a></td><td class="cAI"><p><span></span> <span>phenobarbital</span> <span>possibly reduces plasma concentration of</span> <span>lopinavir</span> <span></span></p></td><td><div class="cG"><p><strong>Note:</strong> In combination with ritonavir as <em>Kaletra</em>® (ritonavir is present to inhibit lopinavir metabolism and increase plasma-lopinavir concentration)—see also Ritonavir</p></div></td></tr><tr><td><a href="bnf_int97-methadone.htm">Methadone</a></td><td><p><span></span> <span>phenobarbital</span> <span>reduces plasma concentration of</span> <span>methadone</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int718-methylphenidate.htm">Methylphenidate</a></td><td><p><span>plasma concentration of </span><span>phenobarbital</span> <span>possibly increased by</span> <span>methylphenidate</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int170-metronidazole.htm">Metronidazole</a></td><td><p><span></span> <span>phenobarbital</span> <span>accelerates metabolism of</span> <span>metronidazole</span> <span>(reduced effect)</span></p></td><td><div class="cG"><p><strong>Note:</strong> Interactions do not apply to topical metronidazole preparations </p></div></td></tr><tr><td><a href="bnf_int254-mianserin.htm">Mianserin</a></td><td class="cAI"><p><span></span> <span>phenobarbital</span> <span>accelerates metabolism of</span> <span>mianserin</span> <span>(reduced plasma concentration)</span></p></td><td></td></tr><tr><td><a href="bnf_int845-montelukast.htm">Montelukast</a></td><td><p><span></span> <span>phenobarbital</span> <span>reduces plasma concentration of</span> <span>montelukast</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int476-nimodipine.htm">Nimodipine</a></td><td class="cAI"><p><span>avoidance of </span><span>phenobarbital</span> <span>advised by manufacturer of</span> <span>nimodipine</span> <span>(plasma concentration of <span>nimodipine</span> reduced)</span></p></td><td></td></tr><tr><td><a href="bnf_int636-oestrogens.htm">Oestrogens</a></td><td class="cAI"><p><span></span> <span>phenobarbital</span> <span>accelerates metabolism of</span> <span>oestrogens</span> <span>(reduced contraceptive effect—see <a title="target-block: COCs interactions" href="PHP4869-combined-hormonal-contraceptives.htm#PHP4875">section 7.3.1</a>)</span></p></td><td><div class="cG"><p><strong>Note:</strong> Interactions of combined oral contraceptives may also apply to combined contraceptive patches and vaginal rings, see <a title="COCs interactions (target-block)" href="PHP4869-combined-hormonal-contraceptives.htm#PHP4875">section 7.3.1</a></p></div></td></tr><tr><td><a href="bnf_int900-oxcarbazepine.htm">Oxcarbazepine</a></td><td><p><span>plasma concentration of </span><span>phenobarbital</span> <span>increased by</span> <span>oxcarbazepine</span><span>, also plasma concentration of an active metabolite of <span>oxcarbazepine</span> reduced</span></p></td><td></td></tr><tr><td><a href="bnf_int59-paracetamol.htm">Paracetamol</a></td><td><p><span></span> <span>phenobarbital</span> <span>possibly accelerates metabolism of</span> <span>paracetamol</span> <span>(also isolated reports of hepatotoxicity)</span></p></td><td></td></tr><tr><td><a href="bnf_int236-paroxetine.htm">Paroxetine</a></td><td><p><span></span> <span>phenobarbital</span> <span>reduces plasma concentration of</span> <span>paroxetine</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int284-phenytoin.htm">Phenytoin</a></td><td><p><span>plasma concentration of </span><span>phenobarbital</span> <span>often increased by</span> <span>phenytoin</span><span>, plasma concentration of <span>phenytoin</span> often reduced but may be increased</span></p></td><td></td></tr><tr><td><a href="bnf_int1237-piperaquine-with-artenimol.htm">Piperaquine with Artenimol</a></td><td><p><span>avoidance of </span><span>phenobarbital</span> <span>advised by manufacturer of</span> <span>piperaquine with artenimol</span> <span></span></p></td><td><div class="cG"><p><strong>Note:</strong> Piperaquine has a long half-life; there is a potential for drug interactions to occur for up to 3 months after treatment has been stopped</p></div></td></tr><tr><td><a href="bnf_int1060-posaconazole.htm">Posaconazole</a></td><td class="cAI"><p><span></span> <span>phenobarbital</span> <span>possibly reduces plasma concentration of</span> <span>posaconazole</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int664-progestogens.htm">Progestogens</a></td><td class="cAI"><p><span></span> <span>phenobarbital</span> <span>accelerates metabolism of</span> <span>progestogens</span> <span>(reduced contraceptive effect—see <a title="target-block: COCs interactions" href="PHP4869-combined-hormonal-contraceptives.htm#PHP4875">section 7.3.1</a>)</span></p></td><td><div class="cG"><p><strong>Note:</strong> Interactions of combined oral contraceptives may also apply to combined contraceptive patches and vaginal rings, see <a href="PHP4869-combined-hormonal-contraceptives.htm#PHP4875">section 7.3.1</a>. For further information on interactions of oral progestogen-only contraceptives, see also <a href="PHP4944-oral-progestogen-only-contraceptives.htm#PHP4945">section 7.3.2.1</a>; parenteral progestogen-only contraceptives, see also <a href="PHP4960-parenteral-progestogen-only-contraceptives.htm#PHP4965">section 7.3.2.2</a>; the intra-uterine progestogen-only device, see also <a href="PHP4973-intra-uterine-progestogen-only-device.htm#PHP4974">section 7.3.2.3</a>; hormonal emergency contraception, see also <a href="PHP5019-hormonal-methods.htm#PHP5024">section 7.3.5</a></p></div></td></tr><tr><td><a href="bnf_int125-propafenone.htm">Propafenone</a></td><td><p><span></span> <span>phenobarbital</span> <span>possibly accelerates metabolism of</span> <span>propafenone</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int793-propranolol.htm">Propranolol</a></td><td><p><span></span> <span>phenobarbital</span> <span>possibly reduces plasma concentration of</span> <span>propranolol</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int231-reboxetine.htm">Reboxetine</a></td><td><p><span></span> <span>phenobarbital</span> <span>possibly reduces plasma concentration of</span> <span>reboxetine</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int201-rifampicin.htm">Rifampicin</a></td><td><p><span></span> <span>phenobarbital</span> <span>possibly reduces plasma concentration of</span> <span>rifampicin</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int1225-rilpivirine.htm">Rilpivirine</a></td><td class="cAI"><p><span>avoidance of </span><span>phenobarbital</span> <span>advised by manufacturer of</span> <span>rilpivirine</span> <span>(plasma concentration of <span>rilpivirine</span> possibly reduced)</span></p></td><td></td></tr><tr><td><a href="bnf_int1102-rufinamide.htm">Rufinamide</a></td><td><p><span></span> <span>phenobarbital</span> <span>possibly reduces plasma concentration of</span> <span>rufinamide</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int791-saquinavir.htm">Saquinavir</a></td><td class="cAI"><p><span></span> <span>phenobarbital</span> <span>possibly reduces plasma concentration of</span> <span>saquinavir</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int1067-sodium-oxybate.htm">Sodium Oxybate</a></td><td><p><span>avoidance of </span><span>phenobarbital</span> <span>advised by manufacturer of</span> <span>sodium oxybate</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int1144-stiripentol.htm">Stiripentol</a></td><td class="cAI"><p><span>plasma concentration of </span><span>phenobarbital</span> <span>increased by</span> <span>stiripentol</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int730-tacrolimus.htm">Tacrolimus</a></td><td class="cAI"><p><span></span> <span>phenobarbital</span> <span>reduces plasma concentration of</span> <span>tacrolimus</span> <span></span></p></td><td><div class="cG"><p><strong>Note:</strong> Interactions do not generally apply to tacrolimus used topically; risk of facial flushing and skin irritation with alcohol consumption (<a title="monograph: TACROLIMUS" href="PHP7780-tacrolimus.htm">see section 13.5.3</a>) does not apply to tacrolimus taken systemically</p></div></td></tr><tr><td><a href="bnf_int1216-telaprevir.htm">Telaprevir</a></td><td class="cAI"><p><span>avoidance of </span><span>phenobarbital</span> <span>advised by manufacturer of</span> <span>telaprevir</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int946-telithromycin.htm">Telithromycin</a></td><td class="cAI"><p><span></span> <span>phenobarbital</span> <span>reduces plasma concentration of</span> <span>telithromycin</span> <span>(avoid during and for 2 weeks after <span>phenobarbital</span>)</span></p></td><td></td></tr><tr><td><a href="bnf_int734-theophylline.htm">Theophylline</a></td><td class="cAI"><p><span></span> <span>phenobarbital</span> <span>accelerates metabolism of</span> <span>theophylline</span> <span>(reduced effect)</span></p></td><td></td></tr><tr><td><a href="bnf_int935-thyroid-hormones.htm">Thyroid Hormones</a></td><td><p><span></span> <span>phenobarbital</span> <span>accelerates metabolism of</span> <span>thyroid hormones</span> <span>(may increase requirements for <span>thyroid hormones</span> in hypothyroidism)</span></p></td><td></td></tr><tr><td><a href="bnf_int857-tiagabine.htm">Tiagabine</a></td><td><p><span></span> <span>phenobarbital</span> <span>reduces plasma concentration of</span> <span>tiagabine</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int1203-ticagrelor.htm">Ticagrelor</a></td><td><p><span></span> <span>phenobarbital</span> <span>possibly reduces plasma concentration of</span> <span>ticagrelor</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int285-topiramate.htm">Topiramate</a></td><td><p><span></span> <span>phenobarbital</span> <span>possibly reduces plasma concentration of</span> <span>topiramate</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int582-toremifene.htm">Toremifene</a></td><td><p><span></span> <span>phenobarbital</span> <span>accelerates metabolism of</span> <span>toremifene</span> <span>(reduced plasma concentration)</span></p></td><td></td></tr><tr><td><a href="bnf_int1163-ulipristal.htm">Ulipristal</a></td><td class="cAI"><p><span>avoidance of </span><span>phenobarbital</span> <span>advised by manufacturer of</span> <span>ulipristal</span> <span>(contraceptive effect of <span>ulipristal</span> possibly reduced)</span></p></td><td></td></tr><tr><td><a href="bnf_int286-valproate.htm">Valproate</a></td><td><p><span>plasma concentration of </span><span>phenobarbital</span> <span>increased by</span> <span>valproate</span> <span>(also plasma concentration of <span>valproate</span> reduced)</span></p></td><td></td></tr><tr><td><a href="bnf_int1227-vandetanib.htm">Vandetanib</a></td><td><p><span>avoidance of </span><span>phenobarbital</span> <span>advised by manufacturer of</span> <span>vandetanib</span> <span>(plasma concentration of <span>vandetanib</span> possibly reduced)</span></p></td><td></td></tr><tr><td><a href="bnf_int768-vitamin-d.htm">Vitamin D</a></td><td><p><span></span> <span>phenobarbital</span> <span>possibly increases requirements for</span> <span>vitamin D</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int948-voriconazole.htm">Voriconazole</a></td><td class="cAI"><p><span></span> <span>phenobarbital</span> <span>possibly reduces plasma concentration of</span> <span>voriconazole</span><span>—avoid concomitant use</span></p></td><td></td></tr><tr><td><a href="bnf_int1040-zonisamide.htm">Zonisamide</a></td><td><p><span></span> <span>phenobarbital</span> <span>reduces plasma concentration of</span> <span>zonisamide</span> <span></span></p></td><td></td></tr></tbody></table><p><strong>Phenobarbital</strong> belongs to <strong>Antiepileptics</strong> and will have the following interaction information:</p><table summary="Drug interactions" width="100%" border="0" cellspacing="2"><colgroup><col width="30%" class="cAG" /><col width="40%" class="cAF" /><col width="30%" class="cAH" /></colgroup><tbody><tr><td><a href="bnf_int232-antidepressants-ssri.htm">Antidepressants, SSRI</a></td><td class="cAI"><p><span>anticonvulsant effect of </span><span>antiepileptics</span> <span>antagonised by</span> <span>SSRIs</span> <span>(convulsive threshold lowered)</span></p></td><td></td></tr><tr><td><a href="bnf_int241-antidepressants-tricyclic.htm">Antidepressants, Tricyclic</a></td><td class="cAI"><p><span>anticonvulsant effect of </span><span>antiepileptics</span> <span>antagonised by</span> <span>tricyclics</span> <span>(convulsive threshold lowered)</span></p></td><td></td></tr><tr><td><a href="bnf_int252-antidepressants-tricyclic-related.htm">Antidepressants, Tricyclic (related)</a></td><td class="cAI"><p><span>anticonvulsant effect of </span><span>antiepileptics</span> <span>possibly antagonised by</span> <span>tricyclic-related antidepressants</span> <span>(convulsive threshold lowered)</span></p></td><td></td></tr><tr><td><a href="bnf_int363-antipsychotics.htm">Antipsychotics</a></td><td class="cAI"><p><span>anticonvulsant effect of </span><span>antiepileptics</span> <span>antagonised by</span> <span>antipsychotics</span> <span>(convulsive threshold lowered)</span></p></td><td><div class="cG"><p><strong>Note:</strong> Increased risk of toxicity with myelosuppressive drugs</p></div></td></tr><tr><td><a href="bnf_int257-maois.htm">MAOIs</a></td><td><p><span>anticonvulsant effect of </span><span>antiepileptics</span> <span>possibly antagonised by</span> <span>MAOIs</span> <span>(convulsive threshold lowered)</span></p></td><td><div class="cG"><p><strong>Note:</strong> For interactions of reversible MAO-A inhibitors (RIMAs) see Moclobemide, and for interactions of MAO-B inhibitors see Rasagiline and Selegiline; the antibacterial Linezolid is a reversible, non-selective MAO inhibitor</p></div></td></tr><tr><td><a href="bnf_int337-mefloquine.htm">Mefloquine</a></td><td class="cAI"><p><span>anticonvulsant effect of </span><span>antiepileptics</span> <span>antagonised by</span> <span>mefloquine</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int856-orlistat.htm">Orlistat</a></td><td class="cAI"><p><span>possible increased risk of convulsions when </span><span>antiepileptics</span> <span>given with</span> <span>orlistat</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int905-st-johns-wort.htm">St John's Wort</a></td><td class="cAI"><p><span>avoid concomitant use of </span><span>antiepileptics</span> <span>with</span> <span>St John's wort</span> <span></span></p></td><td></td></tr></tbody></table><p><strong>Primidone</strong> belongs to <strong>Phenobarbital</strong> but has no specific interaction information.</p><div class="cG"><p><strong>Note:</strong> Primidone interactions as for phenobarbital</p></div></div><div id="pS"><p>Sub-sections</p><ul class="jT"><li><a href="bnf_int1003-primidone.htm" title="Primidone">Primidone</a></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="bnf_int1195-retigabine.htm">Previous: Retigabine</a> | <a class="top" href="bnf_int437-phenobarbital.htm#">Top</a> | <a accesskey="]" href="bnf_int1003-primidone.htm">Next: Primidone</a> ►</div></div></div></div><div id="pF"><div id="p2"><div id="pL"><div class="p4"><h2>Keep in touch</h2><ul><li><a href="http://www.pharmpress.com/?utm_source=medicinescomplete&amp;utm_medium=footer&amp;utm_campaign=medicinescomplete-referral">Pharmaceutical Press</a></li><li><a href="http://www.rpharms.com/">Royal Pharmaceutical Society</a></li><li><a href="http://www.pharmpress.com/mc-alerts.asp?utm_source=medicinescomplete&amp;utm_medium=footer&amp;utm_campaign=medicinescomplete-referral">Sign up for our eNewsletter</a></li><li><a href="http://twitter.com/#!/PharmPress/" class="p5"><img src="../../images/twitter.png" alt="Twitter logo" />Follow us on Twitter
              </a></li><li><a href="http://www.facebook.com/pages/Pharmaceutical-Press/296104187066918" class="p5"><img src="../../images/facebook.png" alt="Facebook logo" />Find us on Facebook
              </a></li></ul></div><div class="p4"><h2>Help and Support</h2><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a></li><li><a href="http://www.medicinescomplete.com/about/contact.htm">Contact Us</a></li><li><a href="privacy.htm" title="Cookie and Privacy Policy">Cookie and Privacy Policy</a></li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a></li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div><div class="p4"><h2>Provided for</h2><div id="cL"><img src="../../images/mylogo.png" alt="BNF.org Free Access" id="pI" /></div></div><div id="pX"><p><a href="PHP0-publication-information.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2013.  All rights reserved.</a></p><p><a href="http://www.medicinescomplete.com/mc/copyright.htm">MedicinesComplete © The Pharmaceutical Press 2013</a></p></div></div></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>